Citigroup
LABD icon

Citigroup’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Citigroup’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-981
Closed -$248K – 6894
2020
Q4 		$248K Sell
981
-17
-2% -$6.48K ﹤0.01% 4827
2020
Q3 		$596K Buy
998
+940
+1,621% +$606K ﹤0.01% 3708
2020
Q2 		$40K Sell
58
-115
-66% -$144K ﹤0.01% 6155
2020
Q1 		$487K Sell
173
-62
-26% -$177K ﹤0.01% 3897
2019
Q4 		$581K Buy
235
+86
+58% +$305K ﹤0.01% 4290
2019
Q3 		$753K Sell
149
-68
-31% -$280K ﹤0.01% 3946
2019
Q2 		$781K Buy
217
+108
+99% +$455K ﹤0.01% 3946
2019
Q1 		$399K Sell
109
-65
-37% -$315K ﹤0.01% 4419
2018
Q4 		$1.49M Buy
174
+20
+13% +$147K ﹤0.01% 2969
2018
Q3 		$752K Buy
154
+76
+97% +$367K ﹤0.01% 3803
2018
Q2 		$405K Buy
78
+67
+609% +$406K ﹤0.01% 4331
2018
Q1 		$82K Buy
+11
New +$76.5K ﹤0.01% 5776
2017
Q4 		– Hold
0
– – – 7331
2017
Q3 		– Hold
0
– – – 7130

Other funds holding LABD

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
HT
Headlands Technologies Chicago, Illinois $878M AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Citigroup's LABD Position: Q1 2025 in Review

Citigroup sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2025, closing a stake of 40 shares — an estimated $2.9K sold.

Citigroup first reported a position in LABD in Q2 2015 and held it in 29 quarters. The position peaked at $12.4M in Q2 2017. 14 funds tracked by Wall St. Rank hold LABD as of Q1 2025.

  • Citigroup reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2025 after selling out during the quarter.
  • Citigroup sold 40 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2025, an estimated $2.9K.
  • Citigroup first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2015 and held it in 29 quarters.
  • Citigroup's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $12.4M in Q2 2017.
  • 14 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2025.

Based on Citigroup's 13F filing for Q1 2025, filed 12 May 2025.